high quality bpc 157 supplement providers BPC-157 – Research Peptide BPC-157 PURE Delayed Release -

Clinical research involving approximately 900 participants across six human trials specifically measured serum IGF-1 concentrations and found no changes with AOD-9604 treatment at doses up to 1 mg per day and beyond

However, certain blood clots (or thrombosis with thrombocytopenia syndrome) have mainly been linked to the Johnson & Johnson vaccine, with cases being identified within two weeks of vaccination

No standardized human dosage

References Pickart L

Gastrointestinal Health: Research indicates BPC-157 could improve digestive disorders, such as healing ulcers and mitigating NSAID-induced damage

The observed effects in test models are thought to be associated with changes in growth hormone and IGF-1 levels